2019 Schedule & Agenda

BIO Asia Webinar Series
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO Asia Webinar Series
Jump to Day
11 Results
Tuesday, March 5
1:45 PM - 2:00 PM (JST)
VORONOI primarily develops small molecule inhibitors of kinases using kinase profiling and…
2:00 PM - 2:15 PM (JST)
CanBas is aiming to find a cure for cancer patients. Its lead oncology drug candidate is a unique…
2:15 PM - 2:30 PM (JST)
Omicsway is specialized on advanced bioinformatics of gene expression data. Our major area is…
2:30 PM - 2:45 PM (JST)
Founded by 2 ex-Quintiles (Now IQVIA) and industry veterans, AUM Biosciences is an oncology-focused…
3:00 PM - 3:15 PM (JST)
ACT Genomics is a leading Asia cancer molecular information company. We partner with biopharma to…
Wednesday, March 6
8:30 AM - 8:45 AM (JST)
AIMM is a preclinical stage company in the process of advancing 2 antibodies into the clinic.
8:45 AM - 9:00 AM (JST)
Kleo Pharmaceuticals is a unique immuno-oncology company developing next-generation bispecific…
9:15 AM - 9:30 AM (JST)
BioInvent International AB (OMXS: BINV), is focused on the discovery and development of novel and…
9:30 AM - 9:45 AM (JST)
AIVITA Biomedical is a clinical stage biotech developing next generation immunotherapies. We…
9:45 AM - 10:00 AM (JST)
Cellerant Therapeutics is a clinical-stage biotech company focused on AML and other blood-related…
10:00 AM - 10:15 AM (JST)
Delta-Fly has been focusing on oncology drug discovery and clinical development from hematologic…